Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
Regeneron (NASDAQ: REGN) Delayed: 789.45 +14.84 (1.92%)
Previous Close $774.61    52 Week High $592.36 
Open $781.18    52 Week Low $325.35 
Day High $789.99    P/E 207.20 
Day Low $774.78    EPS $3.81 
Volume 702,816       

Regeneron (NASDAQ: REGN) Delayed: 789.45 +14.84 (1.92%)
Previous Close $774.61    52 Week High $592.36 
Open $781.18    52 Week Low $325.35 
Day High $789.99    P/E 207.20 
Day Low $774.78    EPS $3.81 
Volume 702,816